Effect of an exercise-based program"TCM Daoyin Prescription" for postsurgical non-small cell lung cancer:study protocol for a randomized controlled trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006061

Enrollment

Unknown

Registered

2022-06-04

Start date

2022-05-30

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Control group:Routine drug therapy (including targeted drug therapy and traditional Chinese medicine therapy) and health education

TCM Daoyin Prescription group:Routine drug therapy (including targeted drug therapy and traditional Chinese medicine therapy) and health education + TCM Daoyin Prescription

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria The eligible participants must meet the following criteria ?aged between 18 and 80 yearshistologically diagnosed with Stage I–IIIA NSCLC according to the 8th edition cancer staging manual of the American Joint Committeeon Cancer and had received surgical therapy; ?Karnofsky performance status of at least =60 at study entry,Neutrophil absolute value > 1.5×109/L, platelet count > 80×109/L, hemoglobin > 100g/L; Normal liver and kidney function and conscious; ?There was no physical disability ?can complete the TCM Daoyin Prescription and the subject has signed an informed consent.

Exclusion criteria

Exclusion criteria: Exclusion ctiteria include the following: ?The patient's condition is concealed; ?Serious complications of other organs and systems; ?History of mental illness, mental and cognitive disorders; ? Malignant tumor cachexia, systemic metastasis of multiple organs; ?Severe cardiopulmonary insufficiency and uncontrolled persistent tachycardia /bradycardia and other malignant arrhythmias, resting systolic blood pressure > 180mmHg or resting diastolic blood pressure >110mmHg; ? Serious physical diseases, unable to cooperate with sports rehabilitation and other unable to complete the subject designated projects. ? Athletes, patients who participated in other traditional rehabilitation sports, participated in any other clinical studies or took their investigational drugs within the last three months

Design outcomes

Primary

Measure	Time frame
cardiorespiratory fitness;	—

Countries

china

Contacts

Public ContactWaiRong Zhao

Longhua hospital Shanghai university of traditional chinese medicine

witoy17@163.com18817773154

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026